Patel HB, Soni ST, Bhagyalaxmi A, Patel NM. Causative agents of urinary tract infections and their antimicrobial susceptibility patterns at a referral center in Western India: an audit to help clinicians prevent antibiotic misuse. J Family Med Prim Care. 2019;8:154–9.

Article  PubMed  PubMed Central  Google Scholar 

Yang X, Chen H, Zheng Y, Qu S, Wang H, Yi F. Disease burden and long-term trends of urinary tract infections: a worldwide report. Front Public Health. 2022;10.

Geerlings SE. Clinical presentations and epidemiology of urinary tract infections. Microbiol Spectr. 2016;4:4.5.03.

Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13:269–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269–284.

Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am. 2014;28:1–13.

Article  PubMed  Google Scholar 

Blango MG, Ott EM, Erman A, Veranic P, Mulvey MA. Forced resurgence and targeting of intracellular uropathogenic Escherichia coli reservoirs. PLoS ONE. 2014;9:e93327.

Article  PubMed  PubMed Central  Google Scholar 

Mysorekar IU, Hultgren SJ. Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc Natl Acad Sci U S A. 2006;103:14170–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fisher RA, Gollan B, Helaine S. Persistent bacterial infections and persister cells. Nat Rev Microbiol. 2017;15:453–64.

Article  CAS  PubMed  Google Scholar 

Kaldalu N, Hauryliuk V, Tenson T. Persisters-as elusive as ever. Appl Microbiol Biotechnol. 2016;100:6545–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Krishna A, Tesfalem Z, Sabyasachy M, Omnia I, Heather S, Leonard V. S, James L. W Evaluation of a sequential antibiotic treatment regimen of ampicillin, ciprofloxacin and fosfomycin against Escherichia coli CFT073 in the hollow fiber infection model compared with simultaneous combination treatment. 26 November 2022.

Niu H, Cui P, Shi W, Zhang S, Feng J, Wang Y, Sullivan D, Zhang W, Zhu B, Zhang Y. Identification of anti-persister activity against uropathogenic Escherichia coli from a clinical drug library. Antibiotics (Basel). 2015;4:179–87.

Article  PubMed  Google Scholar 

Mulcahy LR, Burns JL, Lory S, Lewis K. Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J Bacteriol. 2010;192:6191–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K. Persister cells and tolerance to antimicrobials. FEMS Microbiol Lett. 2004;230:13–8.

Article  CAS  PubMed  Google Scholar 

Mulvey MA, Schilling JD, Martinez JJ,, Hultgren SJ. Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses. Proc Natl Acad Sci U S A. 2000.

Conlon BP, Rowe SE, Gandt AB, Nuxoll AS, Donegan NP, Zalis EA, Clair G, Adkins JN, Cheung AL, Lewis K. Persister formation in Staphylococcus aureus is associated with ATP depletion. Nat Microbiol. 2016;1:16051.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Torrey HL, Keren I, Via LE, Lee JS, Lewis K. High persister mutants in Mycobacterium tuberculosis. PLoS ONE. 2016;11:e0155127.

Article  PubMed  PubMed Central  Google Scholar 

• Bahmaninejad P, Ghafourian S, Mahmoudi M, Maleki A, Sadeghifard N, Badakhsh B. Persister cells as a possible cause of antibiotic therapy failure in Helicobacter pylori. JGH Open. 2021;5:493–7. Demonstrates role of persister cells in recurrence of infection and antibiotic treatment failure.

Article  PubMed  PubMed Central  Google Scholar 

Allison KR, Brynildsen MP, Collins JJ. Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature. 2011;473:216–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luidalepp H, Jõers A, Kaldalu N, Tenson T. Age of inoculum strongly influences persister frequency and can mask effects of mutations implicated in altered persistence. J Bacteriol. 2011;193:3598–605.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alteri CJ, Hagan EC, Sivick KE, Smith SN, Mobley HLT. Mucosal immunization with iron receptor antigens protects against urinary tract infection. PLoS Pathog. 2009;5:e1000586.

Article  PubMed  PubMed Central  Google Scholar 

Gupta K, Trautner BW. Urinary tract infections in the elderly, women, and men. Med Clin North Am. https://doi.org/10.1016/j.mcna.2011.02.013.

Terlizzi ME, Maffei ME, Gribaudo G. Frontiers | UroPathogenic Escherichia coli (UPEC) infections: virulence factors, bladder responses, antibiotic, and non-antibiotic antimicrobial strategies. https://www.frontiersin.org/articles/10.3389/fmicb.2017.01566/full . Accessed 28 Feb 2023.

Høiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 2010;35:322–32.

Article  PubMed  Google Scholar 

Conlon B, Nakayasu E, Fleck L, LaFleur M, Isabella V, Coleman K, Leonard S, Smith R, Adkins J, Lewis K. Killing persister cells and eradicating a biofilm infection by activating the ClpP protease. Nature. 2013;503:365–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

• Zou J, Peng B, Qu J, Zheng J. Are bacterial persisters dormant cells only? Front Microbiol. 2022;12: 708580. Suggests the mechanistic basis for bacterial persistence.

Article  PubMed  PubMed Central  Google Scholar 

Skaar EP. The battle for iron between bacterial pathogens and their vertebrate hosts. PLoS Pathog. 2010;6:e1000949.

Article  PubMed  PubMed Central  Google Scholar 

Mulvey MA, Schilling JD, Hultgren SJ. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun. 2001;69:4572–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pacios O, Blasco L, Bleriot I, et al. (p)ppGpp and its role in bacterial persistence: new challenges. Antimicrob Agents Chemother. 2020;64:e01283–e1320.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Balaban NQ, Merrin J, Chait R, Kowalik L, Leibler S. Bacterial persistence as a phenotypic switch. Science. 2004;305:1622–5.

Article  CAS  PubMed  Google Scholar 

Jahandeh N, Ranjbar R, Behzadi P, Behzadi E. Uropathogenic Escherichia coli virulence genes: invaluable approaches for designing DNA microarray probes. Cent European J Urol. 2015;68:452–8.

CAS  PubMed  PubMed Central  Google Scholar 

Liu S, Wu N, Zhang S, Yuan Y, Zhang W, Zhang Y. Variable persister gene interactions with (p)ppGpp for persister formation in Escherichia coli. Front Microbiol. 2017;8.

Wang X, Wood TK. Toxin-antitoxin systems influence biofilm and persister cell formation and the general stress response ▿. Appl Environ Microbiol. 2011;77:5577–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dong T, Schellhorn HE. Role of RpoS in Virulence of Pathogens. Infect Immun. 2010;78:887–97.

Article  CAS  PubMed  Google Scholar 

Schellhorn HE. Function, evolution, and composition of the RpoS regulon in Escherichia coli. Front Microbiol. 2020;11:560099.

Article  PubMed  PubMed Central  Google Scholar 

Kulesus RR, Diaz-Perez K, Slechta ES, Eto DS, Mulvey MA. Impact of the RNA chaperone Hfq on the fitness and virulence potential of uropathogenic Escherichia coli. Infect Immun. 2008;76:3019–26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Culham DE, Lu A, Jishage M, Krogfelt KA, Ishihama A, Wood JM. The osmotic stress response and virulence in pyelonephritis isolates of Escherichia coli: contributions of RpoS, ProP, ProU and other systems. Microbiology (Reading). 2001;147:1657–70.

Article  CAS  PubMed  Google Scholar 

Kaldalu N, Hauryliuk V, Turnbull KJ, La Mensa A, Putrinš M, Tenson T. In vitro studies of persister cells. Microbiol Mol Biol Rev. 2020;84:e00070–e120.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alam A, Bröms JE, Kumar R, Sjöstedt A. The role of ClpB in bacterial stress responses and virulence. Front Mol Biosci. 2021;8.

Partridge JD, Bodenmiller DM, Humphrys MS, Spiro S. NsrR targets in the Escherichia coli genome: new insights into DNA sequence requirements for binding and a role for NsrR in the regulation of motility. Mol Microbiol. 2009;73:680–94.

Article  CAS  PubMed  Google Scholar 

Leatham-Jensen MP, Mokszycki ME, Rowley DC, et al. Uropathogenic Escherichia coli metabolite-dependent quiescence and persistence may explain antibiotic tolerance during urinary tract infection. mSphere 2016;1:e00055–15.

Schmidt NW, Deshayes S, Hawker S, Blacker A, Kasko AM, Wong GCL. Engineering persister-specific antibiotics with synergistic antimicrobial functions. ACS Nano. 2014;8:8786–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Conlon BP, Nakayasu ES, Fleck LE, LaFleur MD, Isabella VM, Coleman K, Leonard SN, Smith RD, Adkins JN, Lewis K. Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature. 2013;503:365–70.

Article  CAS  PubMed